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a b s t r a c t 
Background: The response of populations to public health measures may rely on the degree to which the 
population trusts sources of information and institutions. There has been little research in this area in 
the Caribbean. This exploratory study aimed to evaluate public trust in information sources, confidence 
in institutions and COVID-19 vaccine willingness in Trinidad and Tobago. 
Methods: An exploratory online survey was conducted in Trinidad and Tobago from November 10 th to 
December 7 th 2020. The survey instrument was a validated questionnaire developed by the World Health 
Organisation (WHO) and adapted to the local setting. Descriptive statistics and regression analyses were 
used to analyse the data. 
Findings: The most trusted sources of information included health workers (32.5%) and the ministry of 
health (23.6 %). Increasing levels of trust in the medical sector were associated with decreasing levels 
of believing misinformation. Overall, 62.8 % of participants said they would take the COVID-19 vaccine 
if available. Regression analyses showed those who agreed that everyone should adhere to the national 
immunization schedule and those who would take the flu vaccine, were 2.77 (95% CI 1.77-4.35) and 4.60 
(95% CI 3.11-6.84) timesmore likely to take the vaccine, respectively. 
Interpretation: Our study found increasing trust in health sources, confidence in medical sector, adher- 
ence to the national immunisation schedule and acceptance of the flu vaccine may increase COVID-19 
vaccine willingness rates. Although the generalisability of the findings is limited, the results of this ex- 
ploratory survey may be used to identify areas for prioritisation and improvement in future research. 
© 2021 The Author(s). Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
Research in context 
Evidence before this study 
Understanding public trust and confidence during health 
emergencies is important as greater levels of trust and confi- 
dence can lead to greater compliance with recommendations 
and measures. Further, knowledge on how populations per- 
ceive their risk may also contribute to the development of ef- 
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fective public health programmes. The acceptance of COVID- 
19 vaccines is also paramount to curbing the pandemic. 
In the Caribbean region, there has been little research 
exploring this area in public health emergencies and pan- 
demics. One previous study conducted in Trinidad and To- 
bago explored public awareness and attitudes towards H1N1 
in 2015. Another study assessed health concerns related to 
COVID-19 in Jamaica. However, this study was limited in the 
variables assessed. As the Caribbean is particularly vulnerable 
to the longer term effects of the pandemic, it is important to 
conduct local and regional research to understand the impact 
of risk perception, where public trust lies and whether the 
population is willing to accept COVID-19 vaccines. 
https://doi.org/10.1016/j.lana.2021.10 0 051 
2667-193X/© 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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Added value of this study 
This exploratory study is the one of the first to evaluate 
public trust, information sources and COVID -19 vaccine will- 
ingness in the English-speaking Caribbean region during the 
current COVID-19 pandemic. The results have shown that less 
than 50% of participants felt they were at risk for contracting 
COVID-19 or developing severe illness. The health sector, in- 
clusive of health workers and the ministry of health were the 
most trusted sources of information and respondents were 
more confident in the health sector compared to non-health 
sector institutions. 
Implications of available evidence 
The findings of this study may provide useful insights 
for a better informed and acceptable pandemic response in 
Trinidad and Tobago. Using trusted sources to communicate 
information on COVID-19 and its associated public health 
measures may promote transparency and increase compli- 
ance with the measures. This may also help to increase and 
sustain public trust. In the longer term, improving health lit- 
eracy and encouraging scientific literacy amongst the general 
population may help individual’s differentiate misinformation 
from accurate information as well as increase a person’s con- 
fidence in the safety and efficacy of the vaccines. Credible in- 
formation on the available vaccines, the vaccination process 
and safety protocols should be shared with the public in or- 
der to alleviate any concerns surrounding the process. 
1. INTRODUCTION 
On March 11 th 2020 the World Health Organisation (WHO) de- 
clared COVID-19 a pandemic. [1] At the time of writing, there are 
approximately 200 million confirmed cases and more than 4 mil- 
lion deaths globally. [2] Alongside this pandemic is the occurrence 
of a parallel emergency, termed the ‘COVID-19 infodemic’. The 
term infodemic refers to an overabundance of information which 
may or may not be accurate. [3] Subsequently, this may lead to is- 
sues surrounding trust, reliability and willingness of populations to 
comply with guidelines.[ 3 , 4 ] 
The response of populations to public health measures may rely 
on the degree to which the population trusts the sources of in- 
formation as well as institutions.[ 5 , 6 ] In the Democratic Repub- 
lic of the Congo, during the Ebola virus outbreak in 2018, a lack 
of trust, misinformation and inaccuracy hampered early effort s to 
control the spread of the infection. [6] Similar patterns are also be- 
ing observed with the COVID-19 pandemic. Patients refused to use 
common pain medication believing that it led to an increased risk 
of contracting COVID-19 and abused other supplements thinking 
it would prevent the spread of the infection. [7] With the grow- 
ing use of social media and the global scale of COVID-19, the risks 
associated with mistrust and misinformation may be greater than 
previous public health emergencies. 
Exploring the factors influencing the risk perceptions and the 
level of public trust and confidence that exists in populations is 
important to a country’s pandemic response. The WHO technical 
advisory group on behavioural insights and science for health iden- 
tified political decision makers, immunization programme man- 
agers, community and religious leaders, health workers, media out- 
lets and digital platforms as groups that influence vaccinations in 
populations. [8] Evaluation of a population’s willingness to accept 
vaccines may help tailor public health measures and strategies to 
increase vaccine uptake. [9] 
Trinidad and Tobago is a twin island developing country in 
the Caribbean with an estimated population of 1.4 million. Pub- 
lic health measures such as border closures, social distancing and 
wearing of face masks were implemented to curb the spread of 
COVID-19 in the country. [10] Currently, there is limited research 
on public perceptions towards infectious diseases as well as vac- 
cines in Trinidad and Tobago and the wider Caribbean. In the 2009 
H1N1 pandemic, less than 2% of the local population were vacci- 
nated with the influenza vaccine, with similar rates noted in other 
Caribbean islands. [11] One previous study in Trinidad and Tobago 
assessed influenza awareness in the general population during an 
outbreak in 2015/2016. The majority of participants did not con- 
sider influenza to be a serious illness and only 52% agreed that 
vaccination was a preventative measure. [12] Although the routine 
immunisation coverage is above 90% for the majority of vaccines 
in Trinidad and Tobago, the low vaccination rates seen during the 
H1N1 pandemic may indicate potential uncertainty with COVID-19 
vaccine acceptance. [13] 
In order to provide timely insights considering the restrictions 
imposed by public health measures, this study therefore aimed to 
conduct a preliminary exploratory survey assessing the levels of 
public trust in information sources, institutions and COVID-19 vac- 
cine willingness among the population in Trinidad and Tobago that 
had access to internet services. 
2. METHODOLOGY 
2.1. Study design and participants 
The study was conducted in Trinidad and Tobago using an on- 
line cross-sectional survey design consisting of members of the 
population with internet access. The survey was approximately 15- 
20 minutes and was disseminated from 10 th November 2020 to 
7 th December 2020. This was approximately ten months after the 
first case was detected in the country and when the country was 
preparing for the implementation of COVID-19 vaccination pro- 
grammes. 
The survey instrument was a validated questionnaire devel- 
oped by the World Health Organisation. [14] As per the WHO 
protocol, the questionnaire was adapted to focus on variables 
considered important and relevant to the local pandemic. The 
adapted survey consisted of 36 closed ended questions inclusive 
of: socio-demographics, COVID-19 personal experience, health lit- 
eracy, COVID-19 risk perception, information sources, confidence 
in institutions, misinformation and conspiracies, COVID-19 vaccines 
and willingness to get tested and share names of contacts (Supple- 
mentary file). 
Online surveys are suitable for time- sensitive situations such as 
this pandemic. They allow rapid data collection while maintaining 
adherence to local public health measures such as limiting face to 
face interactions and physical distancing. [15] This method is easy 
and convenient for responders and has been successfully imple- 
mented in related studies in other countries. [16-18] Participants 
with internet access were eligible to participate once they were 
over the age of 18 years, English speaking, inclusive of nationals 
and non-nationals but residing in Trinidad and Tobago during the 
pandemic period. Participation was voluntary, anonymous and con- 
fidential and no compensation was provided. An online participant 
information and consent sheet was included with the survey. Par- 
ticipants consented to participate in the survey prior to starting 
the survey. Assuming the population size of 1,40 0,0 0 0, that the 
majority of the population had access to internet [19] , 5% margin 
of error, 95% confidence interval and a 50% vaccine acceptance rate, 
the calculated sample size was 385 participants. The sample size 
was increased by 30% to compensate for incomplete responses, du- 
plicate responses or ineligible responses. Thus, the final calculated 
sample size was 500. 
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2.2. Data collection 
The questionnaire was adapted to the local setting and piloted 
on a sample of 20 participants. The pilot focused on an under- 
standing of the questions and facilitated the recognition of con- 
cerns related to survey responses. Minor adjustments to the survey 
were made after the pilot. The survey was self-administered using 
an online platform, Google Forms. The survey was distributed us- 
ing multiple social media platforms including Whatsapp, Twitter, 
LinkedIn and Facebook. The survey was also disseminated using 
professional networks. 
2.3. Patient and public involvement 
Patient and public involvement (PPI) in research has been de- 
fined as research being carried out ‘with’ or ‘by’ members of the 
public rather than ‘to’, ‘about’ or ‘for’ them. [20] Benefits of PPI in- 
clude improving the acceptability and appropriateness of data col- 
lection methods and improving patient information for informed 
consent. [20] Patient and public involvement in research is uncom- 
mon in Trinidad and Tobago. This study incorporated the PPI con- 
cept by involving one public representative, a secondary school 
teacher, in the research process. This representative advised the 
research team on the data collection method and choice of words 
used in the survey and information sheets so that it would be easy 
to understand. 
2.4. Statistical approach 
The analyses were based on the statistical analysis template of 
the WHO protocol [14] with minor necessary adjustments to match 
the modifications in the questionnaire. For descriptive statistics, 
mean, standard deviation, median and interquartile range (IQR) 
were used to describe continuous variables, such as age; while fre- 
quencies were used to describe categorical data, such as gender, 
education level and willingness of getting tested, contact tracing 
and vaccination. All the variables measured by 7-point scale were 
presented as categorical variables in the descriptive statistics and 
were treated as continuous variables in the inferential statistical 
analysis. Variables like trust in non-medical institutions, trust in 
medical sectors and trust in media resources were treated as con- 
tinuous variables, using a mean score across relevant questions. 
Further details can be found in Supplementary Tables 3 and 4. All 
of the above followed the WHO protocol [14] . 
Regression analyses were used to investigate factors that af- 
fected risk perceptions, belief in misinformation/conspiracies and 
willingness to be tested, to share names of contacts and to 
be vaccinated. The full models contained the following predic- 
tors/variables: age, gender, education, chronic disease, health lit- 
eracy, trust in non-medical institutions, in medical sectors or in 
media sources to manage COVID-19, being infected with COVID- 
19, knowing someone who was infected with COVID-19, being a 
health professional and frequency of media consumption. Variables 
such as ‘belief in everyone should be vaccinated according to the 
national immunisation schedule’ and ‘willingness of taking the flu 
vaccine’ were only included when the willingness to be vaccinated 
with a COVID-19 vaccine variable was evaluated. A backward elim- 
ination approach based on the Akaike Information Criterion (AIC) 
was used to obtain the best fit model, following the WHO proto- 
col [14] . All dependent and independent variables are presented in 
supplementary table 1. 
Linear regression was applied to evaluate the factors influenc- 
ing the continuous outcomes, such as risk perception (scale 1-7), 
probability of contracting COVID-19 (scale 1-7), perceived severity 
of illness (scale 1-7), and belief in misinformation and conspira- 
cies (scale 1-7). The answers to each of the four questions un- 
der the misinformation category were first dichotomised into ‘yes’ 
and ‘no’ responses based on the whether or not the information 
was accurate. ‘Yes’ scored 1 and ‘n o’ scored 0. A score of the four 
questions was then taken ((4-Q1-Q2-Q3-Q4)/4). This technique and 
the choice of regression method followed the WHO approach [14] . 
For the belief in conspiracies variable, the answer to the question 
‘many very important things happen in the world which the public 
is never informed about’ was used to present the generic belief in 
conspiracies. 
Binary logistic regression was applied to evaluate factors influ- 
encing the categorical outcomes, such as willingness to be tested, 
to share names of contacts and to be vaccinated with a COVID-19 
vaccine. This was considered the appropriate method since the de- 
pendent variables (i.e. willingness to be tested and to share names 
of contacts) were dichotomised. For ease of understanding, the de- 
pendent variable of willingness to be vaccinated with a COVID-19 
vaccine was also dichotomised. A ‘yes’ to vaccine willingness was 
determined by combining the latter three items in the scale (some- 
what agree, agree, strongly agree). Mean estimates and odds ratios 
were calculated for the linear and logistic regressions respectively. 
Goodness of fit tests, such as R-square and Pearson and deviance 
chi-square tests, were conducted. Confidence intervals of 95% were 
also calculated and p values < 0.05 were considered significant. All 
the analyses were performed using R version 3.6.0. 
3. RESULTS 
3.1. Participant characteristics and COVID-19 Personal Experience 
A total of 642 responses were received during the study period. 
Of these, 27 responses were excluded as they either did not re- 
side in Trinidad and Tobago (n = 11), were less than 18 years (n = 5), 
were incomplete (n = 11). Therefore, 615 responses were analysed. 
The majority of participants were nationals of Trinidad and Tobago. 
The mean age was 31.4 years and the median age was 28 years. Of 
the sample, 31.7% (n = 195) were healthcare professionals. Detailed 
information on participant characteristics are presented in Table 1 . 
Approximately 96.7% (n = 595) of the participants were not pre- 
viously infected with COVID-19. Of those who said they were pre- 
viously infected with COVID-19, 85% (n = 17) classified it as mild 
and 15% (n = 3) classified it as severe. Among those infected, 55% 
(n = 11) stated that the infection was confirmed by a test. When 
participants were asked if anyone in their immediate social envi- 
ronment had been infected by COVID-19, 35.3% (n = 217) said yes. 
Of these participants, 27.6% (n = 60) knew someone who died from 
COVID-19. 
3.2. Risk Perceptions and Health Literacy levels 
When asked about the probability of contracting COVID-19, 
46.5% (n = 286) of participants thought they were likely to contract 
it while 38.0% (n = 234) considered themselves at high risk of con- 
tracting the illness. Approximately 35% (n = 215) felt they would de- 
velop severe illness if they did contract COVID-19. Linear regres- 
sion analyses are presented in Table 2 . Females were more likely to 
think they would develop severe disease if they did have COVID-19 
( β: 0.35; 95% CI: 0.10-0.60). Those who were health professionals 
perceived that they were more likely to contract COVID-19 com- 
pared to those who were not ( β: 1.42; 95% CI: 1.18-1.66). 
Health literacy was assessed by asking five questions related to 
ease of finding and understanding COVID-19 related information. 
The most common response to the questions was ‘easy’ or ‘very 
easy’. However, 20.3% (n = 125) of participants thought it was diffi- 
cult to judge information in the media (supplementary Table 2). 
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Table 1 
Characteristics of Respondents 
Variable Number (N) Percentage (%) 
Nationality 
Trinidad and Tobago 610 99.2 
Other 5 0.8 
Gender 
Male 209 34.0 
Female 406 66.0 
Age 
Mean (standard deviation) 31.4 (10.4) 
Median (interquartile range) 28 (10) 
18-29 331 53.8 
30-39 183 29.7 
40-49 49 8.0 
50-59 38 6.2 
Over 60 14 2.3 
Level of Education 
Up to 9 years (primary and secondary) 45 7.3 
Non-university (technical and vocational 
education) 
50 8.1 
University or higher 520 84.6 
Healthcare Professional 
Yes 195 31.7 
No 420 68.3 
Chronic Illness 
Yes 72 11.7 
No 514 83.6 
Do not know 29 4.7 
County 
Caroni 137 22.3 
Mayaro 18 2.9 
Nariva 7 1.1 
St.Andrews 68 11.1 
St. David 8 1.3 
St. George 166 27.0 
St. Patrick 42 6.8 
Victoria 160 26.0 
Tobago 9 1.5 
Financial Situation 
Improved 57 9.3 
Remained the same 351 57.1 
Worse 191 31.0 
Do not know 16 2.6 
3.3. Trust in information sources and confidence in institutions 
When asked how often they sought information related to 
COVID-19, 49.6% (n = 305) of participants said they never/rarely 
searched for information. Supplementary Tables 3 and 4 present 
results on trust in information sources and confidence in institu- 
tions. The most trusted sources of information were those related 
to the health sector, with most trust placed in the health workers 
(n = 200; 32.5 %) and Ministry of Health (n = 145; 23.6 %). Partici- 
pants were moderately confident or very confident that health in- 
stitutions were capable of managing the COVID-19 pandemic (Hos- 
pitals: n = 212, 34.5 %; Ministry of Health: n = 207, 33.7 %). 
3.4. Belief in Misinformation and Conspiracies 
The most common response to the misinformation questions 
was ‘very untrue of what I believe’ (supplementary Table 5). Ap- 
proximately 32.5 % (n = 200) of participants believed that it was 
probably true that ‘many important things happen which the pub- 
lic are not aware of’ and 41.0 % (n = 252) felt that it was definitely 
true that ‘ politicians usually did not tell their true motives for doing 
things’ (supplementary Table 6). Table 3 presents the regression re- 
sults on belief in misinformation and conspiracy. People with high 
levels of trust in the medical sector were less likely to believe in 
misinformation ( β: -0.03; 95% CI: -0.05- -0.01). Those with lower 
levels of health literacy were more likely to believe in conspiracies 
( β: 0.09; 95% CI: 0.03- 0.15) and misinformation ( β: 0.03; 95% CI: 
0.02- 0.04). 
3.5. Getting tested for COVID-19 and sharing names of contacts 
When asked if they would get tested if exposed to COVID-19 
and if they would share names of contacts if tested positive for 
COVID-19, 83.6 % (n = 514) of participants stated they would get 
tested and 93.8% (n = 577) stated they would share names of con- 
tacts. 
The top two reasons given for why they would not get tested 
were ‘testing would be painful’ (n = 38, 38.8 %) and ‘getting tested 
would cost money’ (n = 33, 33.7 %). When asked for reasons why 
they would get tested for COVID-19, the top two reasons were: 
‘ this way I can protect other people’ (n = 438, 85.5 %) and ‘I want 
to receive the appropriate care in case of a positive test’ (n = 372, 72.7 
%). The top two reasons for participants sharing names of contacts, 
were ‘ this way I can protect other people’ (n = 523, 91.0 %) and ‘I be- 
lieve this helps stop the spread of COVID-19’ (n = 494, 84.9%). When 
asked for reasons why they would not share names of contacts, the 
top two reasons were ‘ I do not trust the authorities’ (n = 18, 48.6 %) 
and ‘I would cause inconvenience for those people whose names are 
shared’ (n = 18, 48.6%). The detailed results for these questions are 
presented in supplementary tables 7 and 8. 
Based on the binary logistic regression analyses ( Table 4 ), in- 
creasing age (OR 0.98, 95% CI: 0.96-1.00), having a chronic ill- 
ness (OR 2.92, 95% CI: 1.26- 8.00), trusting in the medical sector 
(OR1.39, 95% CI 1.19-1.62), not being a health professional (OR 1.66, 
95% CI: 1.05-2.63) and not knowing someone infected with COVID- 
19 (OR 2.01, 95% CI: 1.28-3.16) were all statistically significant for 
getting tested for COVID-19. Higher levels of trust in medical in- 
stitutions (OR 1.95, 95% CI: 1.54-2.52) and not being infected with 
COVID-19 (OR 11.37, 95% CI: 3.48- 34.69) were statistically signifi- 
cant for sharing names of contacts if tested positive for COVID-19. 
3.6. COVID-19 vaccine decisions 
Overall, 62.8% (n = 386) of participants said they would take 
a COVID-19 vaccine if available. In the health professionals sub- 
group, 61.5% (n = 120) agreed they would take a COVID-19 vac- 
cine if available. 76.1% (n = 468) of participants felt that every- 
one should be vaccinated according to the national immunization 
schedule and 63.4% (n = 390) stated they would receive the flu vac- 
cine (supplementary table 1). Regarding, COVID-19 vaccine opin- 
ions, 39.5% (n = 243) of participants strongly disagreed with the 
statement ‘ when everyone is vaccinated against COVID-19, I don’t 
have to get vaccinated too’. (Supplementary table 9). 
Factors influencing the decision to take a COVID-19 vaccine are 
presented in Table 5 . Whether the vaccine had been in use for 
a long time with no serious adverse effects was considered ex- 
tremely important by 44.2 % (n = 272) of participants. Binary lo- 
gistic regression analyses showed those who agreed that everyone 
should adhere to the national immunization schedule and those 
who would take the flu vaccine were 2.77 (95% CI: 1.77- 4.35) and 
4.60 times (95% CI: 3.11- 6.84) more likely to take the vaccine, re- 
spectively ( Table 6 ). 
4. DISCUSSION 
This preliminary exploratory study evaluated the public trust, 
information sources and vaccine willingness amongst the general 
population of Trinidad and Tobago with internet access during the 
current COVID-19 pandemic. The study was conducted ten months 
after the start of the local epidemic at which point there was com- 
munity spread in Trinidad and Tobago. The results of this study 
4 
L. De Freitas, D. Basdeo and H.-I. Wang The Lancet Regional Health - Americas xxx (xxxx) xxx 
ARTICLE IN PRESS 
JID: LANAM [m5G; August 18, 2021;17:54 ] 
Table 2 
Factors associated with probability, risk and severity of COVID-19 
Probability of contracting 
COVID-19 (a) Perceived severity of illness (b) Risk perception (c) 
Predictors Estimates (95% CI) P value Estimates (95% CI) P value Estimates (95% CI) P value 
Age 0,01 (-0.00, 0.02) 0.064 0.01 (0.00, 0.03) 0.025 
Gender 
Male Reference Reference 
Female -0.17 (-0.40, 0.06) 0.151 0.35 (0.10, 0.60) 0.007 
Education level 
Under 9 years -0.58 (-1.01, -0.16) 0.007 -0.16 (-0.62, 0.31) 0.502 -0.54 (-1.02, -0.07) 0.024 
Non-university 0.05 (-0.36, 0.46) 0.812 0.56 (0.12, 1.00) 0.014 0.14 (-0.32, 0.6) 0.554 
University or higher Reference Reference Reference 
Having a chronic illness 
Yes 1.11 (0.74, 1.48) < 0.001 
No or do not know Reference 
Health literacy 0.05 (-0.02, 0.11) 0.139 1.06 (0.98, 1.15) 0.143 
Trust in non-medical institutions to manage COVID-19 -0.14 (-0.23, -0.05) 0.002 -0.14(-0.23, -0.04) 0.005 -0.09 (-0.18, 0.01) 0.081 
Being a health professional 
Yes 1.42 (1.18, 1.66) < 0.001 -0.25 (-0.51, 0.02) 0.065 1.53 (1.27, 1.79) < 0.001 
No Reference Reference Reference 
Being infected with COVID-19 
Yes 0.66 (0.05, 1.28) 0.035 
No Reference 
Knowing someone in your immediate social network 
who has or had COVID-19 
Yes 0.26 (0.03, 0.49) 0.027 -1.39 (-1.87, -1.03) 0.031 0.40 (0.15, 0.66) 0.002 
No Reference Reference 
R 2 / Adjusted R 2 0.25/0.24 0.10/0.09 0.22/0.21 
F-statistics < .001 < .001 < .001 
Note: Linear regression was performed for all three models using the backward elimination approach based on the Akaike Information Criterion for model selection. The 
full model for all three models were adjusted for age (continuous), gender, education level, chronic disease, health literacy (continuous), trust in non-medical institutions 
(continuous), trust in the medical sector (continuous), trust in media sources (continuous), being a health professional, being infected with COVID-19, knowing someone who 
was infected with COVID-19 and frequency of media consumption. 
(a) Probability of contracting COVID-19: What do you consider to be your own probability of getting infected with COVID-19? (1: extremely unlikely; 7: extremely likely) 
(b) Perceived severity of illness: How severe would contracting COVID-19 be for you (how seriously ill do you think you will be)? (1: not severe, 7: very severe). 
(c) Risk perception: How susceptible do you consider yourself to an infection with COVID-19? (1: very low risk, 7: very high risk) 
Table 3 
Factors associated with belief in Misinformation and Conspiracies 
Belief in misinformation (a) General conspiracy belief (b) 
Predictors Estimates (95% CI) P value Estimates (95% CI) P value 
Age 0.09 (0.03, 0.15) 0.075 
Education level 
Under 9 years 0.06 (-0.02, 0.13) 0.152 
Non-university 0.10 (0.03, 0.17) 0.006 
University or higher Reference 
Having a chronic illness 
Yes -0.37 (-0.71, -0.03) 0.035 
No or do not know Reference 
Trust in non-medical institutions to manage COVID-19 0.04 (0.02, 0.06) < 0.001 -0.11 (-0.19, -0.02) 0.014 
Trust in medical sectors to manage COVID-19 -0.03 (-0.05, -0.01) < 0.001 
Health Literacy 0.03 (0.02, 0.04) < 0.001 0.09 (0.03, 0.15) 0.005 
Being a health professional 
Yes -0.08 (-0.12, -0.04) < 0.001 
No Reference 
Being infected with COVID-19 
Yes -1.08 (-1.68, -0.48) < 0.001 
No Reference 
Knowing someone in your immediate social network who has or had COVID-19 
Yes 0.26 (0.03, 0.48) 0.025 
No Reference 
Frequency of media consumption 
Never/Rarely Reference 
Sometimes -0.52 (-0.78, -0.26) < 0.001 
Often/Very often -0.10 (-0.36, 0.16) 0.461 
R 2 /Adjusted R 2 0.11/0.10 0.10 / 0.08 
F-statistics < .001 < .001 
Note: Linear regression was performed for both models using the backward elimination approach based on the Akaike Information Criterion for model selection. The full 
model for both models were adjusted for age (continuous), gender, education level, chronic disease, health literacy (continuous), trust in non-medical institutions (continu- 
ous), trust in the medical sector (continuous), trust in media sources (continuous), being a health professional, being infected with COVID-19, knowing someone who was 
infected with COVID-19 and frequency of media consumption. 
(a) Belief in misinformation: average score of four misinformation questions (0: not misinformed, 1: high misinformed) 
(b) General conspiracy belief: many very important things happen in the world which the public is never informed about. (1: definitely false, 7: definitely true) 
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Table 4 
Factors associated with getting tested for COVID-19 and sharing names of contacts 
Willingness to be tested (a) Willingness to share names of contacts (b) 
Predictors Odds Ratio(95% CI) P value Odds Ratio(95% CI) P value 
Age 0.98 (0.96, 1.00) 0.024 1.03 (0.99, 1.08) 0.130 
Having a chronic illness 
Yes 2.92 (1.26, 8.00) 0.021 
No Reference 
Trust in medical sectors to manage COVID-19 1.39 (1.19, 1.62) < 0.001 1.95 (1.54, 2.52) < 0.001 
Being a health professional 
Yes Reference 
No 1.66 (1.05, 2.63) 0.030 
Being infected with COVID-19 
Yes Reference Reference 
No 2.60 (0.90, 7.00) 0.063 11.37 (3.48, 34.69) < 0.001 
Knowing someone in your immediate social network who has or had COVID-19 
Yes Reference 
No 2.01 (1.28, 3.16) 0.002 
Tjur R 2 0.10 0.10 
Pearson chi-square test 0.24 0.22 
Deviance chi-square test 0.95 0.98 
Note: Binomial logistic regression was performed for both models using the backward elimination approach based on the Akaike Information Criterion for model selection. 
The full model for both models were adjusted for age (continuous), gender, education level, chronic disease, health literacy (continuous), trust in non-medical institutions 
(continuous), trust in the medical sector (continuous), trust in media sources (continuous), being a health professional, being infected with COVID-19, knowing someone who 
was infected with COVID-19 and frequency of media consumption. 
(a) Willingness to be tested: If you have been in contact with someone who tested positive for COVID-19 and have no symptoms yourself – would you get tested if you 
had the opportunity? 
(b) Willingness to share names of contacts: If you test positive for COVID-19 and are asked to share with health authorities the names of people you had been in contact 
with – would you share all names? 
Table 5 















important N (%) 
Whether vaccine has been in use for a 
long time with no serious adverse 
effects 
16 (2.6) 18 (2.9) 25 (4.1) 44 (7.2) 81 (13.2) 159 (25.9) 272 (44.2) 
Whether the vaccine has been in use in 
other countries 
27 (4.4) 26 (4.2) 25 (4.1) 53 (8.6) 100 (16.3) 189 (30.7) 195 (31.7) 
Risk of getting infected at the time the 
vaccine is available 
42 (6.8) 48 (7.8) 36 (5.9) 103 (16.7) 107 (17.4) 146 (23.7) 133 (21.6) 
How easy it is to get the vaccine 66 (10.7) 43 (7.0) 40 (6.5) 98 (15.9) 110 (17.9) 146 (23.7) 112 (18.2) 
Whether the vaccine is free 81 (13.2) 69 (11.2) 46 (7.5) 108 (17.6) 87 (14.1) 122 (19.8) 102 (16.6) 
Whether a high vaccine uptake would lift 
restrictions 
99 (16.1) 66 (10.7) 49 (8.0) 128 (20.8) 74 (12.2) 105 (17.1) 94 (15.3) 
Recommendation from MOH 66 (10.7) 52 (8.5) 57 (9.3) 98 (15.9) 133 (21.6) 118 (19.2) 91 (14.8) 
Country in which vaccine is produced 126 (20.5) 92 (15.0) 56 (9.1) 81 (13.2) 99 (16.1) 91 (14.8) 70 (11.4) 
Recommendation from my family doctor 95 (15.4) 63 (10.2) 42 (6.8) 116 (18.9) 127 (20.7) 111 (18.0) 61 (9.9) 
may have possible implications for the public health approach to 
COVID-19 in Trinidad and Tobago, 
The study found that increasing levels of trust in the medical 
sector were associated with decreasing levels of belief in misinfor- 
mation as well as a greater likelihood of getting tested and shar- 
ing names of contacts. This demonstrates the importance of public 
trust in managing public health emergencies and is consistent with 
results in other settings. [5] In the early phase of the COVID-19 pan- 
demic in the United States, one study found higher levels of trust 
in government sources such as the Centers for Disease and Con- 
trol and lower levels of trust in social media such as Facebook. [5] 
This is important for public health communicators when decid- 
ing which media to use to share information on COVID-19 as well 
as ensuring that these media outlets share accurate and reliable 
information. Our study also found that lower levels of education 
health literacy were associated with increased levels of belief in 
misinformation. Previous studies have shown that belief in misin- 
formation negatively affected compliance with public health mea- 
sures. [6] , [21] , [22] Thus, correcting misinformation, implementing 
targeted health education campaigns and continuing to build trust 
in the medical sector may support compliance with public health 
measures in this pandemic and future public health emergencies. 
Our exploratory study may also provide some early insights 
into the behavioural factors influencing vaccine willingness and 
hesitancy in Trinidad and Tobago. Vaccine hesitancy is a complex 
phenomenon which the WHO has defined as the delay in accep- 
tance or refusal of vaccines despite availability of vaccination ser- 
vices. [23] In our study, 62.8% of participants were willing to take 
a COVID-19 vaccine if available. Similar rates were seen in other 
regional countries such as Paraguay and the Dominican Repub- 
lic while high rates of vaccine willingness (above 80%) were seen 
in Mexico, Brazil and Puerto Rico [18] . In the non-English speak- 
ing Caribbean, Haiti had the lowest rate of vaccine willingness at 
43.6%. [18] In Ghana, a notable increase in vaccine willingness was 
observed from 62.9% in August 2020 to 82.9% in March 2021, after 
the first batch of vaccines arrived in the country. [24] This suggests 
that vaccine decision-making is a dynamic process and may be sit- 
uation dependent. 
The WHO has identified three factors that contribute to vaccine 
hesitancy. These include confidence -trust in vaccine safety and the 
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Table 6 
Factors associated with willingness to take a COVID-19 vaccine 
Willingness to be vaccinated 
with a COVID-19 vaccine (a) 
Predictors Odds Ratios (95% CI) P value 
Gender 
Male Reference 
Female 0.68 (0.45, 1.01) 0.059 
Trust in medical sectors to manage 
COVID-19 
1.16 (1.02, 1.33) 0.023 
Belief in everyone should be vaccinated 
according to the national immunisation 
schedule 
Yes 2.77 (1.77, 4.35) < 0.001 
No Reference 
Willingness of taking flu vaccines 
Yes 4.60 (3.11, 6.84) < 0.001 
No Reference 
Tjur R 2 0.23 
Pearson chi-square test 0.18 
Deviance chi-square test 0.20 
Note: Binomial logistic regression was performed using the backward elimination 
approach based on the Akaike Information Criterion for model selection. The full 
model was adjusted for age (continuous), gender, education level, chronic disease, 
health literacy (continuous), trust in non-medical institutions (continuous), trust in 
the medical sector (continuous), trust in media sources (continuous), being a health 
professional, being infected with COVID-19, knowing someone who was infected 
with COVID-19, frequency of media consumption, everyone should be vaccinated 
according to the national vaccination schedule and willingness of taking flu vac- 
cines. 
(a) Willingness to be vaccinated with a COVID-19 vaccine: If a COVID-19 vaccine 
becomes available and is recommended for me, would you get it? 
health system; complacency - low risk perception resulting in the 
vaccine viewed as unnecessary and convenience -accessibility, af- 
fordability and availability. [25] Most participants in our study had 
high levels of confidence in medical professionals/medical institu- 
tions and considered vaccine safety, risk of infection, cost and ease 
of availability of the vaccine as important factors in their decision- 
making. These may be key areas on which to focus to promote 
vaccine uptake in the country. However, we also found that vac- 
cine willingness in the health professional group was 61.5 %. Vac- 
cinated health professionals are more likely to recommend vac- 
cines to patients. [26] As this group is uniquely placed to influ- 
ence vaccine uptake, it is imperative to build vaccine confidence 
amongst health professionals by addressing their own concerns, 
understanding what factors influence health professionals’ decision 
to accept and recommend the vaccine. 
4.1. Potential practical implications 
In order to promote compliance with public health measures 
and encourage vaccine uptake, two possible strategies may be con- 
sidered, based on the findings of our exploratory survey study. 
Firstly, the various health professional associations should play a 
key role in delivering accurate information to the public since their 
opinions are likely to be highly trusted. This may help individuals 
differentiate misinformation as well as increase a person’s confi- 
dence in the vaccines. 
Secondly, we suggest the government engage communities to 
understand local needs and clearly communicate the reasons for 
implementing public health measures. Although Trinidad and To- 
bago and the Caribbean have performed comparatively well in con- 
taining the pandemic, adequate vaccine uptake in the region is 
an essential element in curbing the pandemic. As COVID-19 vac- 
cination programmes are initiated in Trinidad and Tobago, self- 
reported behaviours, public trust and vaccine opinions may change 
either positively or negatively. Thus, it is important to have contin- 
uous campaigns reinforcing credible information on COVID-19 and 
public health measures. 
4.2. Study strengths and limitations 
This study is one of the first to evaluate public trust, infor- 
mation sources and vaccine willingness in the English-speaking 
Caribbean region during the current COVID-19 pandemic. The 
study used a validated WHO questionnaire tool to conduct the sur- 
vey. Additionally, the results may provide insights to inform public 
health interventions in the country such as developing strategies 
for effective public communication and to support vaccine uptake. 
There are limitations that should be acknowledged. Firstly, the 
survey was cross-sectional in nature and therefore the results are 
specific to that period of time. Secondly, while the online survey 
method has its advantages and allows for our study results to be 
timely generated during the pandemic, it was not possible to use 
probability sampling. Additionally, as a result of the recruitment 
method used for this online survey study it was not possible to 
calculate a response rate. Hence, the generalisability of the find- 
ings to the wider population is limited and results should be in- 
terpreted with caution. However, this survey study is exploratory 
and the results may still be valuable in providing useful insights 
on areas for prioritisation for future research. 
Finally, this study was unable to specifically focus on the grow- 
ing Venezuelan migrant population in Trinidad and Tobago. As mi- 
grant groups are especially vulnerable in the pandemic, a separate 
study should target this sub-population. Details on the mechanism 
behind vaccine hesitancy were beyond the scope of our study and 
should be explored in order to support effective vaccination pro- 
grammes. It would also be useful to conduct qualitative research 
(ensuring adherence to local restrictions) to provide a deeper un- 
derstanding of the factors contributing to vaccine willingness. 
5. CONCLUSION 
This study examined public trust, information sources and vac- 
cine willingness related to COVID-19 in Trinidad and Tobago. Our 
study found that health sources were most trusted by the public 
and increasing trust and confidence in the medical sector may in- 
crease COVID-19 vaccine willingness rates. These results may guide 
public health response activities and identify areas for prioritisa- 
tion and improvement with the ultimate objective being to curb 
the spread of COVID-19 in this country. 
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